Skin reaction following SARS-CoV-2 vaccine BNT162b2

Ital J Dermatol Venerol. 2023 Aug;158(4):360-361. doi: 10.23736/S2784-8671.23.07429-7. Epub 2023 Jun 30.

Authors

Filomena Russo¹, Francesco Santi², Azzurra Sirchio², Laura Lazzeri², Ernesto DE Piano², Paolo Taddeucci², Pietro Rubegni²

Affiliations

¹ Section of Dermatology, Department of Medical, Surgical and Neurological Science, University of Siena, S. Maria alle Scotte Hospital, Siena, Italy - file.russo@libero.it.
² Section of Dermatology, Department of Medical, Surgical and Neurological Science, University of Siena, S. Maria alle Scotte Hospital, Siena, Italy.

PMID: 37387638
DOI: 10.23736/S2784-8671.23.07429-7

No abstract available

MeSH terms

BNT162 Vaccine
COVID-19 Vaccines* / adverse effects
COVID-19* / prevention & control
Humans
SARS-CoV-2

Substances

COVID-19 Vaccines
BNT162 Vaccine